Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
54.65
+9.47 (20.96%)
At close: Mar 6, 2026

HKG:2315 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
33.54-382.95-601.95-545.58
Depreciation & Amortization
165.98179.3174.1128.1
Other Amortization
3.23.15--
Loss (Gain) From Sale of Assets
-0.01-1.830.08-0.39
Loss (Gain) From Sale of Investments
0.36-0.15-44.7-2.13
Loss (Gain) on Equity Investments
29.7510.0314.770.4
Stock-Based Compensation
22.6430.9815.3127.75
Provision & Write-off of Bad Debts
9.44.281.423.12
Other Operating Activities
77.7889.842.0433.13
Change in Accounts Receivable
-96.68-39.02-4.59-35.86
Change in Inventory
-12.933.79-6.4-29.96
Change in Accounts Payable
-47.3511.947.3519.04
Change in Unearned Revenue
30.89.98-8.0716.75
Change in Income Taxes
---0.8-
Change in Other Net Operating Assets
-5.244.168.1719.86
Operating Cash Flow
211.25-76.65-303.27-365.78
Capital Expenditures
-37.13-126.62-240.27-198.67
Sale of Property, Plant & Equipment
1.1126.341.644.76
Divestitures
---6.86-
Investment in Securities
-101.09-91.76109.78
Investing Cash Flow
-137.12-100.28-153.74-84.13
Long-Term Debt Issued
239.33319.91209.6-
Long-Term Debt Repaid
-207.38-172.98-68.77-57.13
Net Debt Issued (Repaid)
31.94146.93140.83-57.13
Issuance of Common Stock
--521.06311.04
Repurchase of Common Stock
-9.51-8.2-18.99-
Other Financing Activities
-114.46-176.55-55.69-34.47
Financing Cash Flow
-92.03-37.82587.2219.44
Foreign Exchange Rate Adjustments
2.753.4714.24-0.38
Net Cash Flow
-15.15-211.28144.44-230.85
Free Cash Flow
174.12-203.26-543.54-564.45
Free Cash Flow Margin
17.76%-28.35%-101.81%-159.20%
Free Cash Flow Per Share
0.44-0.51-1.43-1.56
Cash Interest Paid
31.2824.08177.66
Cash Income Tax Paid
9.320.64--
Levered Free Cash Flow
9.32-231.5-423.55-397.16
Unlevered Free Cash Flow
66.62-169.1-388.46-372.52
Change in Working Capital
-131.39-9.2495.65-10.18
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.